US Stock MarketDetailed Quotes
INBS Intelligent Bio Solutions
- 2.690
- +0.220+8.91%
Close Apr 26 16:00 ET
- 2.610
- -0.080-2.97%
Post 19:33 ET
7.65MMarket Cap-24P/E (TTM)
2.730High2.500Low40.70KVolume2.500Open2.470Pre Close107.76KTurnover1.45%Turnover RatioLossP/E (Static)2.84MShares49.20052wk High2.33P/B7.55MFloat Cap2.28052wk Low--Dividend TTM2.81MShs Float3417.576Historical High--Div YieldTTM9.31%Amplitude2.280Historical Low2.647Avg Price1Lot Size
Intelligent Bio Solutions Key Stats
Quarterly+Annual
YOY
| (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -20.51%-2.87M | 30.73%-1.31M | -119.69%-7.38M | 66.09%-584.34K | -761.82%-2.52M | -67.01%-2.38M | -2,382.65%-1.89M | 70.27%-3.36M | -2.40%-1.72M | 95.26%-292.22K |
| Net income from continuing operations | -362.78%-1.98M | -100.35%-2.43M | -27.96%-10.66M | -27.93%-2.67M | -372.57%-6.35M | 87.67%-427.07K | 15.56%-1.21M | -18.04%-8.33M | -145.60%-2.09M | 57.23%-1.34M |
| Operating gains losses | ---- | ---- | 346.53%9.83K | 112.61%893 | -72,020.00%-7.21K | 99,392.86%13.9K | -27.93%2.25K | 97.06%-3.99K | -693.83%-7.08K | 100.00%-10 |
| Depreciation and amortization | -27.09%290.31K | --307.56K | --966.73K | --170.07K | --398.5K | --398.16K | --0 | --0 | --0 | --0 |
| Other non cash items | -66.47%-133.71K | 300.58%70.96K | -169.26%-1.76M | -783.55%-1.63M | 96.33%-9.43K | -103.16%-80.32K | -275.70%-35.38K | 202.52%2.54M | 462.05%239.15K | ---257.08K |
| Change In working capital | -4.45%-1.01M | 224.58%805.47K | -96.76%78.92K | 1,434.72%2.04M | -126.78%-350.56K | -92.59%-963.71K | -143.17%-646.53K | 149.37%2.44M | 117.36%132.9K | 147.37%1.31M |
| -Change in receivables | 69,239.71%766.07K | -8.91%-431.61K | -76.34%591.79K | -32.83%1.11M | 85.83%-124.06K | 99.86%-1.11K | -115.83%-396.29K | 343.92%2.5M | 261.63%1.66M | ---875.64K |
| -Change in inventory | 162.24%21.88K | ---53.04K | ---345.39K | ---270.52K | ---39.72K | ---35.15K | --0 | --0 | --0 | --0 |
| -Change in payables and accrued expense | -50.80%-1.85M | 9,243.27%1.22M | -65.18%84.5K | 32.64%1.02M | -35.92%299.84K | -194.32%-1.22M | 97.71%-13.3K | 124.94%242.66K | 886.53%770.87K | 37.95%467.91K |
| -Change in other current assets | -72.22%81.7K | 167.35%139.49K | 64.54%-118.34K | 114.34%68.94K | -132.46%-274.32K | 1,095.04%294.15K | -186.20%-207.1K | 88.74%-333.74K | -369.94%-480.6K | 96.20%-118.01K |
| -Change in other current liabilities | -1,123.06%-29.72K | -119.00%-65.34K | -563.15%-133.65K | -866.92%-107.96K | -78.72%1.24K | 555.76%2.91K | -451.25%-29.84K | 32.55%28.86K | 286.52%14.08K | 3,127.62%5.84K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -20.51%-2.87M | 30.73%-1.31M | -119.69%-7.38M | 66.09%-584.34K | -761.82%-2.52M | -67.01%-2.38M | -2,382.65%-1.89M | 70.27%-3.36M | -2.40%-1.72M | 95.26%-292.22K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 73.18%-56.67K | 0 | 21.14%-694.14K | 74.15%-181.75K | 198.08%173.8K | -211.3K | -474.89K | -880.22K | -703.01K | -177.21K |
| Net PPE purchase and sale | -91.75%-56.67K | --0 | -32.85%-505.12K | --0 | 99.62%-678 | ---29.55K | ---474.89K | ---380.22K | ---203.01K | ---177.21K |
| Net business purchase and sale | ---- | ---- | ---189.02K | ---181.75K | --174.48K | ---- | ---- | --0 | --0 | --0 |
| Net investment purchase and sale | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---500K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 73.18%-56.67K | --0 | 21.14%-694.14K | 74.15%-181.75K | 198.08%173.8K | ---211.3K | ---474.89K | ---880.22K | ---703.01K | ---177.21K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1.44M | 46.11K | 1.72M | 0 | 0 | 0 | ||||
| Net issuance payments of debt | ---- | ---- | ---- | ---- | ---65.53K | ---- | ---- | ---- | ---- | --0 |
| Net common stock issuance | ---- | ---- | --2.55M | --0 | --2.55M | ---- | ---- | --0 | --0 | ---- |
| Net preferred stock issuance | ---- | ---- | --220.58K | --0 | --0 | ---- | ---- | --0 | --0 | --0 |
| Net other financing activities | ---- | ---- | ---1.34M | ---54.19K | ---771.31K | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | ---- | --1.44M | --46.11K | --1.72M | ---- | ---- | --0 | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -96.75%186.4K | -81.34%1.54M | -34.48%8.24M | -78.80%2.28M | -73.98%2.91M | -54.45%5.74M | -34.48%8.24M | 2,842.78%12.57M | -24.58%10.76M | -43.70%11.19M |
| Current changes in cash | 129.46%860.34K | 44.62%-1.31M | -56.58%-6.64M | 70.33%-719.98K | -33.57%-627.03K | -104.87%-2.92M | -2,955.07%-2.37M | -135.01%-4.24M | -44.18%-2.43M | 91.71%-469.43K |
| Effect of exchange rate changes | -19.37%72.27K | 69.30%-39.01K | 33.22%-64.86K | 74.53%-23.32K | -111.79%-4.11K | 1,060.78%89.62K | -163.70%-127.05K | -343.00%-97.13K | -1,686.38%-91.57K | -22.61%34.9K |
| End cash Position | -61.57%1.12M | -96.75%186.4K | -81.34%1.54M | -81.34%1.54M | -78.80%2.28M | -73.98%2.91M | -54.45%5.74M | -34.48%8.24M | -34.48%8.24M | -24.58%10.76M |
| Free cash flow | -21.38%-2.93M | 44.62%-1.31M | -110.86%-7.88M | 69.66%-584.34K | -436.63%-2.52M | -69.08%-2.41M | -2,955.07%-2.37M | 66.91%-3.74M | -14.46%-1.93M | 92.38%-469.43K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg